Cutler Group LP Aurinia Pharmaceuticals Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	SELL	$7.13 - $9.49 $3,565 - $4,745	-500 Reduced 83.33%	100 $0
Q3 2023 Nov 07, 2023	SELL	$7.77 - $12.27 $13,986 - $22,086	-1,800 Reduced 75.0%	600 $0
Q2 2023 Jul 18, 2023	SELL	$8.96 - $11.69 $103,040 - $134,435	-11,500 Reduced 82.73%	2,400 $1,000
Q1 2023 May 01, 2023	BUY	$5.94 - $11.27 $71,280 - $135,240	12,000 Added 631.58%	13,900 $8,000
Q4 2022 Feb 07, 2023	SELL	$4.11 - $8.14 $822 - $1,628	-200 Reduced 9.52%	1,900 $0
Q3 2022 Oct 25, 2022	SELL	$6.66 - $12.39 $29,304 - $54,516	-4,400 Reduced 67.69%	2,100 $0
Q2 2022 Aug 04, 2022	SELL	$8.95 - $12.8 $539,685 - $771,840	-60,300 Reduced 90.27%	6,500 $2,000
Q1 2022 Apr 14, 2022	SELL	$10.05 - $22.48 $796,965 - $1.78 Million	-79,300 Reduced 54.28%	66,800 $22,000
Q4 2021 Jan 18, 2022	BUY	$17.78 - $33.08 $654,304 - $1.22 Million	36,800 Added 33.67%	146,100 $230,000
Q3 2021 Oct 26, 2021	BUY	$10.93 - $23.55 $1.03 Million - $2.22 Million	94,400 Added 633.56%	109,300 $266,000
Q2 2021 Jul 19, 2021	BUY	$10.0 - $14.52 $139,000 - $201,828	13,900 Added 1390.0%	14,900 $8,000
Q1 2021 Apr 26, 2021	SELL	$12.3 - $18.73 $126,690 - $192,919	-10,300 Reduced 91.15%	1,000 $1,000
Q4 2020 Jan 21, 2021	BUY	$12.94 - $16.05 $24,586 - $30,495	1,900 Added 20.21%	11,300 $5,000
Q3 2020 Oct 27, 2020	SELL	$13.19 - $16.66 $56,717 - $71,638	-4,300 Reduced 31.39%	9,400 $3,000
Q2 2020 Jul 22, 2020	SELL	$14.12 - $18.33 $14,120 - $18,330	-1,000 Reduced 6.8%	13,700 $18,000
Q1 2020 May 07, 2020	SELL	$11.34 - $21.46 $144,018 - $272,542	-12,700 Reduced 46.35%	14,700 $23,000
Q4 2019 Feb 06, 2020	BUY	$3.88 - $21.42 $99,716 - $550,494	25,700 Added 1511.76%	27,400 $165,000
Q1 2019 May 10, 2019	BUY	$6.06 - $7.64 $4,242 - $5,348	700 Added 70.0%	1,700 $3,000
Q4 2018 Feb 05, 2019	SELL	$5.08 - $6.83 $24,384 - $32,784	-4,800 Reduced 82.76%	1,000 $1,000
Q3 2018 Nov 07, 2018	BUY	$5.27 - $6.64 $1,580 - $1,992	300 Added 5.45%	5,800 $8,000
Q2 2018 Aug 10, 2018	BUY	$5.06 - $6.36 $3,541 - $4,452	700 Added 14.58%	5,500 $5,000
Q1 2018 May 11, 2018	BUY	$4.85 - $5.99 $969 - $1,198	200 Added 4.35%	4,800 $0
Q4 2017 Jan 17, 2018	SELL	$4.53 - $7.09 $282,219 - $441,707	-62,300 Reduced 93.12%	4,600 $1,000
Q3 2017 Oct 17, 2017	BUY	$5.71 - $6.9 $381,999 - $461,610	66,900	66,900 $27,000

Others Institutions Holding AUPH

# of Institutions

227

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

Black Rock Inc. New York, NY

9.27M
Shares

$74.6 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

8.43M
Shares

$67.9 Million
5.69% of portfolio
Armistice Capital, LLC New York, NY

6.4M
Shares

$51.5 Million
0.81% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$32 Million
2.55% of portfolio
State Street Corp Boston, MA

2.92M
Shares

$23.5 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account